JONATHAN COUCHMAN

CIK 1265094 · President and CEO · last filed 2025-08-20

JONATHAN COUCHMAN is a President and CEO who has filed 13 SEC Form 4 insider transactions across 2 companies since 2009.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

13

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ENZO BIOCHEM INC (ENZ) Delisted Director 272,897 $0.31 $85.6K $0 1 2025-01-17
PERNIX THERAPEUTICS HOLDINGS, INC. (GTA) Delisted Director $0 2 2010-01-20

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-08-20 Disp (D) −605,134 $0
2025-01-17 ENZO BIOCHEM INC (ENZ) Delisted Grant (A) +142,897 $0 EDGAR
2020-03-31 Buy (P) +2,610,892 $365.1K
2020-03-27 Buy (P) +1,958,169 $273.8K
2019-01-09 Buy (P) +2,995,206 $775.8K
2012-04-26 Other (J) +11,063,578 $0
2010-01-20 PERNIX THERAPEUTICS HOLDINGS, INC. (GTA) Delisted Grant (A) $0 EDGAR
2009-11-25 PERNIX THERAPEUTICS HOLDINGS, INC. (GTA) Delisted Grant (A) $0 EDGAR
2008-12-10 Grant (A) +169,492 $0
2008-07-22 Grant (A) +12,370 $0
Showing 110 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.